Merlin CP-GEP™ Demonstrates Superior Predictive Accuracy for Sentinel Lymph Node Metastasis in Early-Stage Melanoma

SkylineDx today announced the publication of new data by Dr. Wesley Yu, et al ²., demonstrating that Merlin CP-GEP identifies ...
Medscape

Skipping Lymph Node Biopsy Gains Ground in Early Breast Cancer

New data show growing adoption of guidance to skip sentinel lymph node biopsy in older women with early breast cancer, though ...

SkylineDx: Merlin CP-GEP Demonstrates Superior Predictive Accuracy for Sentinel Lymph Node Metastasis in Early-Stage Melanoma

Peer-reviewed publication confirms Merlin CP-GEP¹ identifies a subset of T1a patients with SLN positivity above guideline thresholdsTwo Independent validations at Leading Academic Centers reported ...